Concourse Financial Group Securities, Inc. Amarin Corp Plcuk Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 8,000 shares of AMRN stock, worth $3,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,000
Previous 8,000
-0.0%
Holding current value
$3,520
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMRN
# of Institutions
177Shares Held
65.1MCall Options Held
258KPut Options Held
98K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$10.9 Million3.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$5.46 Million0.64% of portfolio
-
Eversept Partners, LP New York, NY3.31MShares$1.46 Million0.16% of portfolio
-
Morgan Stanley New York, NY2.55MShares$1.12 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.1 Million1.16% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $177M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...